Enforced MYC expression directs a distinct transcriptional state during plasma cell differentiation
Life Science Alliance · 2025
DOI: 10.26508/lsa.202402814 ↗Kurz gefasst
Fachartikel in der Zeitschrift Life Science Alliance, 2025. Verfasst von Panagiota Vardaka und 11 weiteren Autor:innen. Beteiligte Einrichtung: Division of Haematology and Immunology, Leeds Institute of Medical Research, University of Leeds, Leeds, UK. Hauptthemen laut MEDLINE: Plasma Cells, Cell Differentiation, Proto-Oncogene Proteins c-myc. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 97 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome Trust, Cancer Research UK Programme Grant, Cancer Research UK - FC AECC / AIRC under the Accelerator Award Program.
Abstract (Originalsprache)
MYC provides a rheostat linking cell growth and division. Deregulation of MYC drives transformation in aggressive B-cell neoplasms, often accompanied by BCL2-mediated apoptotic protection. We assess how MYC and BCL2 deregulation impacts on the ability of human B cells to complete plasma cell (PC) differentiation. As B cells differentiate, MYC deregulation has little impact on the regulatory circuitry controlling B-cell identity. Induction of transcriptional regulators BLIMP1 and IRF4 remains intact and accompanies loss of B-cell surface markers. However, such differentiating cells develop an aberrant surface phenotype with reduced expression of phenotypic markers of differentiation. Although functional antibody secretion is established, enforced MYC expression dampens the expression of secretory programmes associated with PC differentiation. Accompanying this, diverse changes in the expression of genes related to translation and metabolism are observed. The establishment of this aberrant differentiated state depends on MYC homology box II. This dependence is profound and resolves to residue W135.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Division of Haematology and Immunology, Leeds Institute of Medical Research, University of Leeds, Leeds, UK.
- Epidemiology and Cancer Statistics Group, Department of Health Sciences, University of York, York, UK.
- NIHR Leeds BRC, Leeds, UK.
- Haematological Malignancy Diagnostic Service, Leeds Teaching Hospitals NHS Trust, Leeds, UK.
- Welcome MRC Cambridge Stem Cell Institute, Cambridge, UK.
- Division of Haematology and Immunology, Leeds Institute of Medical Research, University of Leeds, Leeds, UK r.tooze@leeds.ac.uk.
ORCID-Profile: Panagiota Vardaka, Ben Kemp, Eden Page, Michelle Umpierrez, Adam Annahar, Eleanor O'Callaghan, Daniel J Hodson, Reuben M Tooze
Förderung
- Wellcome Trust
- Cancer Research UK Programme Grant
- Cancer Research UK - FC AECC / AIRC under the Accelerator Award Program
- Blood Cancer UK Project Grant
- National Institute for Health and Care Research (NIHR) Leeds Biomedical Research Centre (BRC)
- Cancer Research UK (CRUK)
- National Institute for Health and Care Research
- Blood Cancer UK
Zitieren
APA
Vardaka, P., Kemp, B., Stephenson, S., Page, E., Care, M. A., Umpierrez, M., Annahar, A., O'Callaghan, E., Owen, R., Hodson, D. J., Doody, G. M., & Tooze, R. M. (2025). Enforced MYC expression directs a distinct transcriptional state during plasma cell differentiation. Life Science Alliance. https://doi.org/10.26508/lsa.202402814
Vancouver
Vardaka P, Kemp B, Stephenson S, Page E, Care MA, Umpierrez M, et al. Enforced MYC expression directs a distinct transcriptional state during plasma cell differentiation. Life Science Alliance. 2025. doi:10.26508/lsa.202402814
BibTeX
@article{Vardaka2025,
author = {Vardaka, Panagiota and Kemp, Ben and Stephenson, Sophie and Page, Eden and Care, Matthew A and Umpierrez, Michelle and Annahar, Adam and O'Callaghan, Eleanor and Owen, Roger and Hodson, Daniel J and Doody, Gina M and Tooze, Reuben M},
title = {Enforced MYC expression directs a distinct transcriptional state during plasma cell differentiation},
journal = {Life Science Alliance},
year = {2025},
doi = {10.26508/lsa.202402814}
}
EUVIMED